Elidel pimecrolimus dermatology data

In the 26-week, double-blind, vehicle-controlled (PEP study3) trial in 521 patients aged 2-17 years, mean number of flare-ups was reduced to 0.84 with Elidel vs. 1.68 for control. Median time to first...